|
| | 103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024 HB1121 Introduced 1/12/2023, by Rep. Will Guzzardi SYNOPSIS AS INTRODUCED: |
| |
Amends the Overdose Prevention and Harm Reduction Act. Provides that a trained overdose responder for an organization enrolled in the Drug Overdose Prevention Program administered by the Department of Human Services, Division of Substance Use Prevention and Recovery may dispense drug adulterant testing supplies to any person. Provides that drug adulterant testing supplies shall be stored so that they are accessible only by trained overdose responders.
|
| |
| | A BILL FOR |
|
|
| | HB1121 | | LRB103 02814 SPS 47820 b |
|
|
1 | | AN ACT concerning health.
|
2 | | Be it enacted by the People of the State of Illinois,
|
3 | | represented in the General Assembly:
|
4 | | Section 5. The Overdose Prevention and Harm Reduction Act |
5 | | is amended by changing Section 10 as follows: |
6 | | (410 ILCS 710/10) |
7 | | Sec. 10. Dispensing of drug adulterant testing supplies. A |
8 | | pharmacist, physician, advanced practice registered nurse, or |
9 | | physician assistant, or the pharmacist's, physician's, |
10 | | advanced practice registered nurse's, or physician assistant's |
11 | | designee, or a trained overdose responder for an organization |
12 | | enrolled in the Drug Overdose Prevention Program administered |
13 | | by the Department of Human Services, Division of Substance Use |
14 | | Prevention and Recovery may dispense drug adulterant testing |
15 | | supplies to any person. Any drug adulterant testing supplies |
16 | | dispensed under this Section must be stored at a licensed |
17 | | pharmacy, hospital, clinic, or other health care facility , or |
18 | | at the medical office of a physician, advanced practice |
19 | | registered nurse, or physician assistant , or at the premises |
20 | | of the organization enrolled in the Drug Overdose Prevention |
21 | | Program. Drug adulterant testing supplies shall also be stored |
22 | | so that they are accessible only by and in a manner that limits |
23 | | access to the drug adulterant testing supplies to pharmacists, |